How do I find recruiting Acute Myeloid Leukemia clinical trials?

Browse the actively recruiting Acute Myeloid Leukemia studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.

Are Acute Myeloid Leukemia clinical trials free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

Who can take part in a Acute Myeloid Leukemia clinical trial?

Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.

Acute Myeloid Leukemia Clinical Trials

Acute Myeloid Leukemia clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for acute Myeloid Leukemia. Corterve aggregates actively recruiting Acute Myeloid Leukemia studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.

Browse all Acute Myeloid Leukemia trials Take the assessment

Recruiting Acute Myeloid Leukemia studies

A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
NCT07751991PHASE1Charm TherapeuticsAML (Acute Myeloid Leukemia)Duarte, California
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
NCT07437950PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaCoeur d'Alene, Idaho
Individualized AML Treatment
NCT07613385City of Hope Medical CenterRelapsed/Refractory Acute Myeloid Leukemia (AML)Duarte, California
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
NCT06129734PHASE1, PHASE2Benjamin TomlinsonMyeloid MalignancyCleveland, Ohio
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
NCT06917911PHASE2National Cancer Institute (NCI)Core Binding Factor Acute Myeloid LeukemiaBirmingham, Alabama
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
NCT05554393PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaBirmingham, Alabama
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
NCT07223814PHASE3Stichting Hemato-Oncologie voor Volwassenen NederlandAcute Myeloid LeukemiaLos Angeles, California
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
NCT06317649PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaBirmingham, Alabama
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
NCT06672146PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaTucson, Arizona
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
NCT00801489PHASE2M.D. Anderson Cancer CenterAcute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Houston, Texas
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
NCT06017258PHASE1Memorial Sloan Kettering Cancer CenterRefractory Acute Myeloid LeukemiaBasking Ridge, New Jersey
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
NCT07007312PHASE3Kura Oncology, Inc.Acute Myeloid Leukemia (AML)Gilbert, Arizona

See all 241 recruiting trials →

Acute Myeloid Leukemia trials by state

Acute Myeloid Leukemia trials by metro

Frequently asked questions

How do I find recruiting Acute Myeloid Leukemia clinical trials?: Browse the actively recruiting Acute Myeloid Leukemia studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
Are Acute Myeloid Leukemia clinical trials free to join?: Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
Who can take part in a Acute Myeloid Leukemia clinical trial?: Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.